首页> 美国卫生研究院文献>Journal of Enzyme Inhibition and Medicinal Chemistry >Synthesis and biological evaluation of 3-arylcoumarin derivatives as potential anti-diabetic agents
【2h】

Synthesis and biological evaluation of 3-arylcoumarin derivatives as potential anti-diabetic agents

机译:3-芳基香豆素衍生物作为潜在抗糖尿病药的合成及生物学评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A variety of substituted 3-arylcoumarin derivatives were synthesised through microwave radiation heating. The method has characteristics of environmental friendliness, economy, simple separation, and purification process, less by-products and high reaction yield. Those 3-arylcoumarin derivatives were screened for antioxidant, α-glucosidase inhibitory and advanced glycation end-products (AGEs) formation inhibitory. Most compounds exhibited significant antioxidant and AGEs formation inhibitory activities. Anti-diabetic activity studies showed that compounds >11 and >17 were equipotent to the standard drug glibenclamide in vivo. According to the experimental results, the target compound >35 can be used as a lead compound for the development of new anti-diabetic drugs. The whole experiment showed that anti-diabetic activity is prevalent in 3-arylcoumarins, which added a new natural skeleton to the development of anti-diabetic active drugs.
机译:通过微波辐射加热合成了多种取代的3-芳基香豆素衍生物。该方法具有环境友好,经济,分离纯化工艺简单,副产物少,反应收率高的特点。对那些3-芳基香豆素衍生物进行了抗氧化剂,α-葡糖苷酶抑制和晚期糖基化终产物(AGEs)形成抑制的筛选。大多数化合物显示出显着的抗氧化剂和AGEs形成抑制活性。抗糖尿病活性研究表明,化合物> 11 和> 17 在体内与标准药物glibenclamide等效。根据实验结果,目标化合物> 35 可用作开发抗糖尿病药物的先导化合物。整个实验表明,抗糖尿病活性在3-芳基香豆素中普遍存在,这为抗糖尿病活性药物的开发增加了新的天然骨架。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号